Post-diagnostic statin use and survival in hormone receptor-positive early breast cancer

Women with early hormone receptor-positive breast cancer who use statins after diagnosis have lower breast cancer-specific mortality than non-users, according to a large Finnish population study, with findings supporting further evaluation of statins as a potential adjunct to standard treatment. The population-based retrospective cohort study, published in the journal JAMA Network Open, examined the association […] The post Post-diagnostic statin use and survival in hormone receptor-positive early breast cancer appeared first on Hospital Healthcare Europe .